ProCE Banner Activity

CE / CME

Growing Pains: Overcoming Challenges in the Management of Adult Growth Hormone Deficiency

In this engaging, interactive video roundtable, expert faculty discuss the clinical management of adults with GHD, including proper diagnosis, current and emerging therapies, barriers to treatment, and strategies to improve the transition from pediatric to adult GHD management.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Nurses: 1.00 Nursing contact hour

Released: February 17, 2022

Expiration: February 16, 2023

No longer available for credit.

Share

Faculty

Mark E. Molitch

Mark E. Molitch, MD

Professor Emeritus
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Patience H. White

Patience H. White, MD, MA

Professor Emeritus
Department of Medicine and Pediatrics
George Washington University School of Medicine and Health Sciences
Senior Medical Director, The National Alliance
Co-Director, Got Transition
Washington, DC

Kevin C.J. Yuen

Kevin C.J. Yuen, MD, FRCP (UK), FACE

Professor of Medicine
Department of Neuroendocrinology and Neurosurgery
Barrow Neurological Institute
Medical Director
Barrow Neuroendocrinology Clinic
Barrow Pituitary Center
Phoenix, Arizona

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk

Partners

Endocrine Nurses Society

ProCE Banner

National Alliance Adolescent Health

ProCE Banner

Target Audience

This program is intended for pediatric and adult endocrinologists, endocrinology nurses, nurse practitioners, physician assistants, and pharmacists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize the recommendations for testing and diagnosis in adults with GHD
  • Analyze the safety, efficacy, and dosing of approved and emerging treatment options for adults with GHD
  • Apply strategies to overcome barriers with adherence for adults with GHD and for young adults with GHD as they transition into adult care

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Mark E. Molitch, MD

Professor Emeritus
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Mark E. Molitch, MD, has disclosed that he has received funds for research support from Bayer, Chiasma, Crinetics, Novartis, Recordati, and Strongbridge; consulting fees from Chiasma, Recordati, and Strongbridge; and other financial or material support from Corcept and Janssen.

Patience H. White, MD, MA

Professor Emeritus
Department of Medicine and Pediatrics
George Washington University School of Medicine and Health Sciences
Senior Medical Director, The National Alliance
Co-Director, Got Transition
Washington, DC

Patience H. White, MD, MA, has no relevant conflicts of interest to report.

Kevin C.J. Yuen, MD, FRCP (UK), FACE

Professor of Medicine
Department of Neuroendocrinology and Neurosurgery
Barrow Neurological Institute
Medical Director
Barrow Neuroendocrinology Clinic
Barrow Pituitary Center
Phoenix, Arizona

Kevin C.J. Yuen, MD, FRCP (UK), FACE, has disclosed that he has received funds for research support from Amryt, Ascendis, Corcept, and Crinetics; consulting fees from Amryt, Ascendis, Corcept, Crinetics, Ipsen, Novo Nordisk, Recordati, and Strongbridge; and fees for non-CME/CE services from Corcept, Novo Nordisk, and Recordati.

Staff Disclosure

Staff

Robin Black, PharmD, BCACP

Scientific Director

Robin Black, PharmD, BCACP, has no relevant conflicts of interest to report.

Ruth Cohen,

Ruth Cohen Cooper, CHCP, has no relevant conflicts of interest to report.

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Anna Poppa,

Managing Editor, HIV
Clinical Care Options, LLC

Anna Poppa has no relevant conflicts of interest to report.

Julie Skowronski, FNP-BC

Julie Skowronski, FNP-BC, has no relevant conflicts of interest to report.

Daniel Thibodeau, MPH, PA-C, DFAAPA

Editorial Contributor

Daniel Thibodeau, MPH, PA-C, DFAAPA, has disclosed that he has received consultings fees from Azurity.

Instructions for Credit

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UAN JA4008176-0000-22-049-H01-P.

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for maximum of 1.0 hour of AAPA Category I CME credit. Approval is valid until February 16, 2023. PAs should only claim commensurate with the extent of their participation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 17, 2022, through February 16, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to educate endocrinologists and other healthcare professional about current challenges and unmet needs related to clinical management of adult patients with GHD and those transitioning into adulthood so that they incorporate professional recommendations into patient care.